To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Paul Stoffels (b. 8 March, 1962, Turnhout, Belgium) is a Belgian MD, who studied Medicine at the University of Hasselt and the University of Antwerp (UA). In addition he studied Infectious Diseases and Tropical Medicine at the Prince Leopold Institute of Tropical Medicine in Antwerp, Belgium. He is a son of Lode Stoffels, who led the chemical factory of Janssen Pharmaceutica in Geel, Belgium.
Additional recommended knowledge
Stoffels worked for 4 years as a physician and researcher of HIV/AIDS in Africa, where he met Peter Piot. In 1991, he returned to Belgium and became the Head of Development for the HIV compounds at Janssen Pharmaceutica in Beerse, Belgium. In 1993 he was promoted to Director of Clinical Research and Development for Infectious Diseases and Dermatology. In 1997, he left Janssen Pharmaceutica and co-founded the biotech companies Tibotec and Virco. When Johnson & Johnson acquired Tibotec-Virco in April 2002, he became Company Group Chairman of the Global Virology Franchise at Johnson & Johnson and Chairman of Tibotec.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Paul_Stoffels". A list of authors is available in Wikipedia.|